Improving TelePrEP Initiation and Retention Outcomes in the US: The MISTR+ Study
Part of paid clinical trials in Atlanta, Georgia.
- Sponsor
- Emory University
- Study ID
- NCT07821671
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- No Marginal Cost Interventions — BEHAVIORALThe exact intervention types will be determined based on Aim 1 data analyses that seek to identify the areas that could most benefit from intervention. Possible interventions to be tested include message content, message format, message time of day, and website design.
- Low-Marginal Cost Interventions — BEHAVIORALThe exact intervention types will be determined based on Aim 1 data analyses that seek to identify the areas that could most benefit from intervention. Possible interventions to be tested include warm handoffs, personalized messages, and enhanced remote laboratory testing.
- Standard of Care — BEHAVIORALMISTR users receive the current standard of care. The standard of care will be updated as impactful interventions are identified.
Study Details
This study uses a rapid randomized controlled trial (RCT) design to examine HIV pre-exposure prophylaxis (PrEP) delivered through telehealth. This study will develop a knowledge base of small, effective changes to digital messaging and website design to improve telemedicine PrEP (telePrEP) provision for MISTR users in the United States.
Key Dates
- First listed
- Sep 16, 2026
- Start date
- Mar 1, 2027
- Status verified
- Sep 2026
- Primary completion
- May 31, 2031
- Completion
- May 31, 2031
Study Design
- Enrollment
- 223,165 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Intervention ConditionIndividuals using MISTR services receiving an intervention condition.
- Active Comparator: Control ConditionIndividuals using MISTR services receiving the standard of care.
Primary Outcome Measure
Number of Participants Initiating PrEP [ Time Frame: Through the intervention period (2 to 4 months) ]
Central Contacts
- Aaron Siegler, PhD404-712-9733
- Rebecca Moges-Banks, MPH
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Emory University Rollins School of Public Health | Atlanta | Georgia | 30322 | - |
Find similar trials in Atlanta, GA
Nationwide
By condition
By specialty
By research site
Related Studies
- Baricitinib for Reduction of HIV - CNSPHASE2 · Recruiting · William Tyor · Atlanta, Georgia
- Low Dose Naltrexone for Pain in Patients With HIVPHASE4 · Recruiting · Emory University · Atlanta, Georgia
- Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIVPHASE1 · Not Yet Recruiting · Emory University · Atlanta, Georgia
- Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC VirusPHASE2 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas